How can we help?
Spasticity
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- Cannabinoids in the management of spasticity associated with multiple sclerosis
- Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
- Efficacy, safety, and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
- Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
- Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review